Nicholas N. Vahanian
2016
In 2016, Nicholas N. Vahanian earned a total compensation of $4.4M as President & Chief Medical Officer at NewLink Genetics, a 7% increase compared to previous year.
Compensation breakdown
| Bonus | $43,000 |
|---|---|
| Non-Equity Incentive Plan | $143,575 |
| Option Awards | $1,939,848 |
| Salary | $574,300 |
| Stock Awards | $1,705,000 |
| Other | $44,200 |
| Total | $4,449,923 |
Vahanian received $1.9M in option awards, accounting for 44% of the total pay in 2016.
Vahanian also received $43K in bonus, $143.6K in non-equity incentive plan, $574.3K in salary, $1.7M in stock awards and $44.2K in other compensation.
Rankings
In 2016, Nicholas N. Vahanian's compensation ranked 1,930th out of 14,075 executives tracked by ExecPay. In other words, Vahanian earned more than 86.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,930 out of 14,075 | 86th |
Division Manufacturing | 662 out of 5,489 | 88th |
Major group Chemicals And Allied Products | 185 out of 1,895 | 90th |
Industry group Drugs | 131 out of 1,538 | 92nd |
Industry Pharmaceutical Preparations | 104 out of 1,176 | 91st |
Source: SEC filing on March 31, 2017.
Vahanian's colleagues
We found five more compensation records of executives who worked with Nicholas N. Vahanian at NewLink Genetics in 2016.
2016
Charles Link
NewLink Genetics
Chief Executive & Scientific Officer
2016
John Henneman
NewLink Genetics
Chief Financial Officer
2016
Brian Wiley
NewLink Genetics
Chief Commercial Officer
2016
Eugene Kennedy
NewLink Genetics
Chief Medical Officer
2016
Carl Langren
NewLink Genetics